Cargando…
Commentary: Combating COVID-19-associated mucormycosis with limited resources
Autores principales: | Kim, Usha, Kulkarni, Pooja, Saini, Pragya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9359250/ https://www.ncbi.nlm.nih.gov/pubmed/35648005 http://dx.doi.org/10.4103/ijo.IJO_1250_22 |
Ejemplares similares
-
Frontal osteomyelitis post-COVID-19 associated mucormycosis
por: Kulkarni, Pooja, et al.
Publicado: (2023) -
Commentary: COVID-19-associated mucormycosis: The ongoing battle
por: Nair, Akshay Gopinathan
Publicado: (2021) -
Commentary: Data and COVID-19-associated mucormycosis: Time to pause and reassess?
por: Nair, Akshay Gopinathan
Publicado: (2022) -
Impact of COVID-19 pandemic on primary care research in a resource-limited setting: a commentary
por: Michael, Godpower Chinedu, et al.
Publicado: (2020) -
The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India
por: Chakrabarti, Sankha Shubhra, et al.
Publicado: (2022)